Russian COVID-19 vaccine to enter circulation on January 1, 2021

Russia’s Health Ministry has registered the vaccine against the coronavirus infection developed by the Gamaleya Research Center as a solution for injections. It will appear in circulation starting on January 1, 2021, the website of the State Register of Pharmaceuticals reported on Tuesday.
"Date of introduction to the civilian circulation - 01.01.2021," the site noted.
Binnopharm JSC and the Gamaleya research center are listed as manufacturers.
It had been reported that the Gamaleya center had developed two forms of the vaccine - a liquid and a freeze-dried one.
Russia’s Health Minister Mikhail Murashko reported on Tuesday that the vaccine against the coronavirus infection will be produced in Russia on two sites. According to him, currently with the assistance of the Industry and Trade Ministry and the Sberbank project office "technical regulations are being worked through in order to scale the production on sites of several domestic manufacturers."
Medical workers and teachers will be the first to get the COVID-19 vaccine, Russian Health Minister Mikhail Murashko said during a session between Russian President Vladimir Putin and members of the government.
"We will begin the stage-by-stage civilian use of the vaccine. First and foremost, we would like to offer vaccination to those who come into contact with infected persons at work. These are medical workers. And also, those who are responsible for children’s health - teachers," the minister said.



Source